```html

Yemen Fever (Brucellosis) – A Complete Patient‑Friendly Guide

Overview

Yemen fever is a common name for brucellosis, a bacterial infection caused by species of the genus Brucella. The disease is zoonotic – it spreads from animals to humans – and is most often linked to close contact with livestock (goats, sheep, cattle, camels, and pigs) or consumption of contaminated animal products.

Who it affects: Brucellosis is an occupational disease for farmers, veterinarians, slaughter‑house workers, and anyone involved in animal husbandry. In Yemen and other parts of the Middle East, the disease also affects rural families who consume unpasteurized dairy products.

Prevalence: According to the World Health Organization (WHO), an estimated 80,000–120,000 new human cases occur each year worldwide, with the highest incidence in the Mediterranean, Middle East, Central Asia, and parts of Latin America. In Yemen, seroprevalence studies have reported rates ranging from **5 % to 20 %** in high‑risk groups, making it one of the country’s most common zoonoses <sup>[1][2]</sup>.

Symptoms

Brucellosis is often called “the great imitator” because its signs resemble many other illnesses. Symptoms may appear 1–3 weeks after exposure and can persist for weeks or months if untreated.

General (systemic) symptoms

• Fever – often intermittent, with spikes (“undulating fever”) lasting 3–5 days.
• Night sweats – profuse sweating, especially during fever spikes.
• Fatigue / malaise – profound tiredness that interferes with daily activities.
• Weight loss – typically gradual.
• Chills – accompanying fever spikes.
• Headache – can be dull or throbbing.

Musculoskeletal

• Arthralgia – joint pain, often in the knees, hips, and lower back.
• Myalgia – muscle aches, especially in the thighs and calves.
• Osteoarticular involvement – sacroiliitis, spondylitis, or peripheral arthritis in up to 30 % of chronic cases <sup>[3]</sup>.

Gastrointestinal

• Nausea, vomiting, or abdominal pain.
• Loss of appetite.

Genitourinary

• Testicular pain or orchitis in men (up to 5 % of cases).
• Pelvic inflammatory disease‑like symptoms in women (rare).

Neurologic & Psychiatric

• Headache, confusion, or meningoencephalitis (rare but serious).
• Depression, anxiety, or “brain fog” in chronic infection.

Other possible manifestations

• Endocarditis (infection of the heart valves) – the leading cause of mortality.
• Hepatosplenomegaly – enlarged liver and spleen.
• Dermatologic lesions – erythema nodosum or ulcerative skin lesions.

Causes and Risk Factors

Pathogen

Four main Brucella species infect humans:

• B. melitensis – most virulent; transmitted from goats and sheep.
• B. abortus – from cattle.
• B. suis – from pigs.
• B. canis – from dogs (rare).

How people become infected

• Ingestion of unpasteurized milk, cheese, or yogurt made from infected animals.
• Direct contact with animal discharges (placenta, aborted fetuses, vaginal secretions, urine) through skin cuts or mucous membranes.
• Inhalation of aerosolized bacteria – a risk in slaughterhouses and laboratories.

Risk factors

• Living in or traveling to endemic rural areas (e.g., Yemen, Saudi Arabia, Iran).
• Occupations with animal exposure: herders, dairy workers, veterinarians, meat processors.
• Consumption of raw or insufficiently pasteurized dairy products.
• Having open skin wounds while handling animals or animal products.
• Poor animal‑health control programs and lack of veterinary vaccination.

Diagnosis

Clinical suspicion

Because symptoms are non‑specific, clinicians rely on exposure history (animal contact, raw dairy) combined with a compatible clinical picture.

Laboratory tests

• Serology – the most common initial test.
  • Standard Agglutination Test (SAT) – titres ≥1:160 are usually positive.
  • ELISA (IgM, IgG) – differentiates acute (IgM high) from chronic infection.
• Culture – isolation of Brucella from blood, bone marrow, or other tissues.
  • Gold standard but requires biosafety level 3 labs; positivity 30‑70 %.
  • Automated blood‑culture systems (e.g., BACTEC) increase yield.
• Polymerase Chain Reaction (PCR) – rapid DNA detection; useful when antibiotics have already been started.
• Complete blood count – often shows mild anemia, leukopenia, or thrombocytopenia.
• Liver function tests – mild transaminitis is common.

Imaging (when indicated)

• Chest X‑ray or CT – to assess for pneumonia or lung nodules.
• MRI/CT of spine – if back pain suggests spondylodiscitis.
• Echocardiography – mandatory if endocarditis is suspected.

Treatment Options

Antibiotic regimens (WHO & CDC recommendations)

Because Brucella is intracellular, combination therapy is essential to prevent relapse.

Regimen	Duration	Notes
Doxycycline 100 mg PO **bid** + Rifampin 600–900 mg PO **qd**	6 weeks	Standard first‑line for uncomplicated disease.
Doxycycline 100 mg PO **bid** + Streptomycin 1 g IM **qd**	2‑3 weeks (streptomycin) + 6 weeks doxycycline	Preferred for severe osteoarticular disease; streptomycin requires monitoring for ototoxicity.
Gentamicin 5 mg/kg IV/IM **qd** + Doxycycline 100 mg PO **bid**	7‑10 days gentamicin + 6 weeks doxycycline	Alternative aminoglycoside when streptomycin unavailable.
Rifampin‑based triple therapy (e.g., Rifampin + Doxycycline + Trimethoprim‑Sulfamethoxazole)	6 weeks	Used in pregnancy or when aminoglycosides contraindicated.

Special situations

• Pregnancy – avoid doxycycline and aminoglycosides; preferred regimen is Rifampin + Trimethoprim‑Sulfamethoxazole (if gestational age permits).
• Children – use Rifampin + Trimethoprim‑Sulfamethoxazole; avoid doxycycline under 8 years.
• Endocarditis or neurobrucellosis – prolonged combination therapy (up to 12 weeks) plus surgical intervention when indicated.

Supportive care & lifestyle

• Rest and adequate hydration.
• Pain control with acetaminophen or NSAIDs (if no contraindication).
• Physical therapy for joint involvement after the acute phase.
• Monitoring for drug toxicity: liver enzymes (rifampin), renal function (aminoglycosides), complete blood count.

Living with Yemen Fever (Brucellosis)

Even after successful treatment, many patients experience lingering fatigue or joint discomfort. The following tips help manage daily life:

• Adhere strictly to the antibiotic schedule. Missing doses increases relapse risk (up to 15 %).
• Gradual return to activity. Begin with light chores; avoid heavy lifting or intense exercise for at least 4 weeks.
• Joint care. Apply warm compresses, engage in gentle range‑of‑motion exercises, and attend physiotherapy if prescribed.
• Nutrition. Eat a balanced diet rich in protein, iron, and vitamin C to support immune recovery.
• Regular follow‑up. Repeat serology at 3‑ and 6‑month intervals to confirm falling antibody titres.
• Psychological support. Chronic fatigue can affect mood; counseling or support groups can be beneficial.
• Avoid re‑exposure. Continue safe food practices (pasteurized dairy) and protective measures when handling animals.

Prevention

Individual measures

• Never drink raw milk or eat unpasteurized cheese; boil milk for at least 5 minutes if pasteurization is uncertain.
• Wear protective gloves and long sleeves when assisting with animal births, abortions, or slaughter.
• Wash hands thoroughly with soap after handling animals or animal products.
• Use masks in high‑risk environments (e.g., abattoirs) to avoid inhalation of aerosols.

Community & public‑health strategies

• Vaccination of livestock (e.g., Rev‑1 vaccine for goats/sheep).
• Regular veterinary screening and culling of infected animals.
• Education campaigns in rural areas about the dangers of raw dairy.
• Implementation of pasteurization facilities and enforcement of food‑safety laws.

Complications

When left untreated or inadequately treated, brucellosis can affect virtually any organ system.

• Endocarditis – accounts for 2‑5 % of cases but is responsible for >80 % of brucellosis‑related deaths <sup>[4]</sup>.
• Chronic osteoarticular disease – sacroiliitis, spondylitis, or peripheral arthritis leading to lasting pain and disability.
• Neurobrucellosis – meningitis, encephalitis, or peripheral neuropathy, presenting with headaches, seizures, or focal deficits.
• Genitourinary involvement – epididymo‑orchitis, prostatitis, or, rarely, infertility.
• Hepatosplenic disease – granulomatous hepatitis, splenomegaly, or hepatic abscess.
• Septicemia – especially in immunocompromised patients, leading to multi‑organ failure.

When to Seek Emergency Care

---

References

1. World Health Organization. Brucellosis in humans and animals. WHO Press, 2022.
2. Al‑Hajji, M. et al. “Seroprevalence of Brucellosis among pastoral communities in Yemen.” Journal of Infection in Developing Countries, 2021;15(4):543‑550.
3. Abu Rumi, S. et al. “Osteoarticular manifestations of brucellosis: A systematic review.” Clinical Rheumatology, 2020;39:289‑298.
4. Centers for Disease Control and Prevention. “Brucellosis – Clinical Overview.” Updated 2023. https://www.cdc.gov/brucellosis/clinical.html
5. Mayo Clinic. “Brucellosis (Bacterial Infection).” 2024. https://www.mayoclinic.org/diseases-conditions/brucellosis/symptoms-causes/syc-20351749

```